FHC | Farmacêutica is a global supplier of healthcare products and a worldwide reference in the supply chain of medicinal products and other healthcare products and a full-liner operator of products and logistic solutions in the sector.
FHC | Farmacêutica leads FHC Group, holding a set of subsidiaries, that act transversally in the human health area.
We are passionate about developing, manufacturing, distributing and providing excellence services in the pharmaceutical sector
At FHC Group we are passionate about developing, manufacturing, distributing and providing excellence services in the pharmaceutical sector, as part of a global holistic commitment of contributing to the improvement of the pharmaceutical sector, based on the updated and integrated experience, as well as on the knowledge of the companies of the group operating in the sector for more than 70 years.
Constitution of FHC Farmacêutica
Entrance in the share capital of Empifarma
Entrance in the share capital of Overpharma
Expansion of FHC Farmacêutica logistics facilities to 1,500 m³, in Mortágua
Acquisition of financial participation in Laboratórios Basi and beginning of products distribution in the national market
Constitution of Phagecon, a company dedicated to providing services to the pharmaceutical sector
Acquisition of the total capital of Laboratórios BASI
Creation of Actrádia, S.A, a company dedicated to the management of the group’s real estate assets
Transformation of Empifarma in a public limited company and beginning of the pre-wholesale operation
Constitution of Zeone, a company dedicated to the provision of services and consultancy in the IT area
Construction of a Quality Control laboratory for Laboratórios Basi, with GMP approval, in Mortágua
Construction of the new Liquid and Semi-solid Production Unit of Laboratórios Basi, in Mortágua
Constitution of Actrádia Consultoria, a company dedicated to providing shared services
Acquisition of the total capital of Paracélsia
Development, by Zeone, of the B2B software Magium Farma
Empifarma acquires a Knapp's robotic logistics unit, with 9,000 m2 of covered area, in Montemor-o-Velho and begins the operation of general distribution (pharmacies) and promotion through Magium
Acquisition of 100% of the company Laphysan (Spain), a company dedicated to the distribution and marketing of pharmaceutical products
Design of the Project for the Production Unit of Injections of Laboratórios Basi, in Mortágua
Construction of the Production Unit of Injections of Laboratórios Basi in Mortágua
Manufacturer’s Authorisation (EudraGMP) for the Production unit of Injections of Laboratórios Basi, in Mortágua
Empifarma completes the expansion project of a new Knapp’s robotic logistics unit, in Famões (Lisbon)
FHC, having a deep knowledge in the pharmaceutical supply chain, allowed a quick and effective action in the response to COVID-19, supplying the necessary equipment to several countries and national health authorities to contain the spread of the virus
Basi became members of iBET – Instituto de Biologia Experimental e Tecnológica and obtained certification in Quality (NP EN ISO 9001:2015), Environment (NP BN ISO 14001:2015) and Safety (ISO 4500:2018)
Constitution of Basinnov Life Sciences
Implementation of the ISO 50001:2018 Energy Management Process, in Basi
Basi obtained Recognition of Suitability in terms of Research and Development, by ANI
Acquisition of a financial stake in the company Mozpharma (MZ)
Basi announces a strategic investment and partnership with TargTex, a private biotechnology company which develops an innovative and novel treatment for brain tumours
Basi and Beta-i • collaborative innovation launches global co-innovation program for oncology and immunotherapy
Creation of Pharma Academy, Training Academy
Requalification of the Headquarters Building of the FHC Group
Acquisition of a financial stake in the company Grasshopper (PT)
Constitution of SVP Pharma (UK)
Constitution of Guinepharma (GE)
Constitution of Vitamed (BR)
Acquisition of a financial stake in the company Worldrugs (PT)
Acquisition of a financial stake in the company Socifarma (AO)
Acquisition of a financial stake in the company Mecofama (AO)
Disposal of a financial stake in the company Phagecon (PT)
Alienação de participação financeira na empresa Saluspharma (GW e ST)
Turnover
Equity
EBITDA
Employees
In the last 25 years, the group has accumulated relevant experience in several areas of the pharmaceutical sector, developing its business activity in the Health sector, focusing in all pharmaceutical value chain.
We actively work for unmet needs of patients and consumers on a global scale, making healthcare products affordable, contributing to the health and well-being of millions of people in more than 60 countries.
We are present directly in 7 geographies, which allows us to operate in an integrated way in these markets, from consulting and monitoring services in Pharmaceutical Regulatory Affairs, to promotion and local Logistics & Distribution operations.
